Poster

Mechanistic QSP Modeling to Support KIT Inhibitor Dose Selection, Biomarker Strategy, and Clinical Development

Discover how a mechanistic quantitative systems pharmacology (QSP) model predicts mast cell inhibition and depletion…

Certara2026 年 6 月 16 日

On-Demand Webinar

Building IND-Ready and Investor-Ready Development Programs

Learn how emerging biotechs can build IND-ready, investor-ready development programs using Totality of Evidence, NAMs,…

Certara2026 年 6 月 15 日

Blog

Data, models, and modalities: Key themes from the Certainty 2026 Discovery UGM

A recap of the Certainty 2026 Discovery UGM in Boston, covering the top themes from…

Certara2026 年 6 月 15 日

Brochure

2026 Simcyp Workshops

Advance your PBPK and model-informed drug development expertise with Simcyp workshops. Learn from experts through…

Certara2026 年 6 月 11 日

Blog

QSP modeling for Parkinson’s disease: Solving the synthetic control challenge in clinical trials

QSP modeling for Parkinson’s disease tackles optimized standard-of-care, placebo response, and missing biomarkers. See how…

Certara2026 年 6 月 11 日

Live Events

机制性 MIDD：凭借坚实的科学基础实现监管成功

2026 年 6 月 30 日 - 12:00 PM – 2:00 PM

Certara2026 年 6 月 10 日

On-Demand Webinar

Model Smarter, Not Harder: Introducing Model Designer

Watch Model Designer on demand: Certara's browser based tool for faster NLME model discovery, configuration,…

Certara2026 年 6 月 10 日

Poster

Population Pharmacokinetic Modeling to Predict Absorbed and Biologically Effective Dose for Radioligand Therapies

Explore how population PK modeling predicts absorbed dose and biologically effective dose for radioligand therapies.

Certara2026 年 6 月 9 日

Press Coverage

支持模拟孕妇用药剂量的理由

孕妇通常被排除在药物临床试验之外，这使得临床医生缺乏用药剂量的指导。Discover how…

Certara2026 年 6 月 9 日

Publication

Clinical Validation of a QSP Model for ISB 2001, a Trispecific T Cell Engager to Support Optimal FIH Study Design in RRMM Patients

See how a QSP model guided efficacy-proximal FIH dosing for ISB 2001 in the TRIgnite-1…

Certara2026 年 6 月 4 日

建模与模拟